Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Invesco S&P 500 High Div Low Volatility ETF (SPHD) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Invesco S&P 500 High Div Low Volatility ETFTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Invesco S&P 500 High Div Low Volatility ETF vs Vir Biotechnology Inc. Common Stock — how do they compare? Invesco S&P 500 High Div Low Volatility ETF trades at $49.78 (market cap $3.20B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Invesco S&P 500 High Div Low Volatility ETF is the larger of the two by market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Invesco S&P 500 High Div Low Volatility ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Invesco S&P 500 High Div Low Volatility ETF for 126 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

SPHDVIR
Market Cap
$3.20B$1.80B
Volume
1,075,2301,782,836
52-Week High
$53.55$11.78
52-Week Low
$46.96$5.12
Typical Hold Time
126 Days0 Days
Sector
—Health
Enterprise Value
—$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Invesco S&P 500 High Div Low Volatility ETF

SPHD, the Invesco S&P 500 High Dividend Low Volatility ETF, trades at $49.29, up 0.1% on the day. Technical indicators show a mixed picture with a bullish overall signal but bearish moving averages, while the RSI suggests mild overbought conditions. The ETF focuses on high dividend yields and low volatility, attracting income-focused investors, though recent news highlights performance comparisons with peers like SCHD.

The outlook for SPHD hinges on its dividend strategy amid market volatility. Opportunities include steady income for retirees, but risks involve underperformance versus growth-focused ETFs and sensitivity to interest rate changes. Investors should weigh the trade-off between yield and total return potential.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SPHD
40% Buy60% Sell
Avg holding period · 126 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Invesco S&P 500 High Div Low Volatility ETF

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the “index Provider”) compiles, maintains and calculates the underlying index, which is designed to measure the performance of 50 least volatile high yielding constituents of the S&P 500 ® Index in the past year.

Read more on SPHD →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →